当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:574.96亿  总市值:724.75亿
流通股本:21.18亿   总股本:26.70亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金30,773,141,374.9120,208,100,300.6410,133,330,424.1341,012,673,920.75
  收到的税费返还253,122,403.14184,554,340.7870,159,723.75481,786,382.91
  收到其他与经营活动有关的现金1,185,817,322.69996,338,870.54227,734,707.591,677,687,518.11
  经营活动现金流入小计32,212,081,100.7421,388,993,511.9610,431,224,855.4743,172,147,821.77
  购买商品、接受劳务支付的现金11,176,691,619.617,145,888,018.583,479,707,841.6615,087,001,072.37
  支付给职工以及为职工支付的现金8,507,722,635.455,929,869,192.953,136,229,307.2111,060,190,509.88
  支付的各项税费2,054,188,939.251,464,706,738.36603,284,720.792,606,074,067.94
  支付其他与经营活动有关的现金7,091,709,340.724,714,529,067.762,156,323,107.369,941,900,909.36
  经营活动现金流出小计28,830,312,535.0319,254,993,017.659,375,544,977.0238,695,166,559.55
  经营活动产生的现金流量净额3,381,768,565.712,134,000,494.311,055,679,878.454,476,981,262.22
二、投资活动产生的现金流量:
  收回投资收到的现金2,217,629,391.751,625,743,729.781,070,446,951.42409,580,356.92
  取得投资收益收到的现金226,566,471.52134,793,660.8697,771,441.761,088,797,294.92
  处置固定资产、无形资产和其他长期资产收回的现金净额42,136,833.161,924,563.542,256,980.45457,808,960.28
  处置子公司及其他营业单位收到的现金净额181,376,314.58172,736,314.581,000,000131,424,365.62
  收到的其他与投资活动有关的现金220,302,827.7777,465,182.17103,848,787.75317,711,213.11
  投资活动现金流入小计2,888,011,838.782,012,663,450.931,275,324,161.382,405,322,190.85
  购建固定资产、无形资产和其他长期资产支付的现金3,168,540,323.032,073,906,530.231,118,595,389.464,410,191,178.59
  投资支付的现金892,030,051.91544,580,781.7774,571,745.98846,041,301.52
  取得子公司及其他营业单位支付的现金33,976,446.7--215,794,112.61
  支付其他与投资活动有关的现金305,297,457.93253,913,153.89267,248,411.34546,618,969.35
  投资活动现金流出小计4,399,844,279.572,872,400,465.891,460,415,546.786,018,645,562.07
  投资活动产生的现金流量净额-1,511,832,440.79-859,737,014.96-185,091,385.4-3,613,323,371.22
三、筹资活动产生的现金流量:
  吸收投资收到的现金195,288,551.57134,789,848.5777,763,335.05204,728,600.1
  其中:子公司吸收少数股东投资收到的现金195,288,551.57134,789,848.5777,763,335.05204,728,600.1
  取得借款收到的现金26,346,546,129.0816,192,026,243.136,496,493,638.7330,931,111,057.51
  收到其他与筹资活动有关的现金327,480,095.01521,751,778.55137,512,764.82,233,435,288.69
  筹资活动现金流入小计26,869,314,775.6616,848,567,870.256,711,769,738.5833,369,274,946.3
  偿还债务支付的现金26,629,633,045.3116,176,838,838.916,575,538,058.6230,520,787,294.33
  分配股利、利润或偿付利息支付的现金2,060,586,501.09777,894,219.56314,313,635.862,461,097,387.21
  其中:子公司支付给少数股东的股利、利润351,893,007.84180,177,918.9112,494,331.81401,677,759.28
  支付其他与筹资活动有关的现金1,423,521,850.451,354,035,085.6455,545,332.941,389,976,602.12
  筹资活动现金流出小计30,113,741,396.8518,308,768,144.077,345,397,027.4234,371,861,283.66
  筹资活动产生的现金流量净额-3,244,426,621.19-1,460,200,273.82-633,627,288.84-1,002,586,337.36
四、汇率变动对现金及现金等价物的影响-80,826,833.379,762,529.48,912,313.0327,989,327.43
五、现金及现金等价物净增加额-1,455,317,329.64-176,174,265.07245,873,517.24-110,939,118.93
  加:期初现金及现金等价物余额9,391,449,787.119,391,449,787.119,391,449,787.119,502,388,906.04
  期末现金及现金等价物余额7,936,132,457.479,215,275,522.049,637,323,304.359,391,449,787.11
补充资料:
  净利润-2,100,210,564.8-3,512,440,385
  资产减值准备-64,269,906.34-96,569,884.79
  固定资产和投资性房地产折旧-773,788,060.53-1,543,138,675.38
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-773,788,060.53-1,543,138,675.38
  无形资产摊销-632,373,736.11-1,038,687,347.67
  长期待摊费用摊销-103,945,371.05-169,436,132.07
  处置固定资产、无形资产和其他长期资产的损失--2,116,774.07--371,013,112.68
  固定资产报废损失-5,430,528.51-21,714,578.69
  公允价值变动损失-48,596,693.14-115,939,368.11
  财务费用-556,338,581.92-1,254,072,720.22
  投资损失--2,120,176,697.39--2,104,607,405.87
  递延所得税-159,056,091.8--360,778,770.32
  其中:递延所得税资产减少-7,946,457.27--254,965,765.39
    递延所得税负债增加-151,109,634.53--105,813,004.93
  存货的减少-490,624,923.63-238,192,005.32
  经营性应收项目的减少--421,230,400.73--397,523,060.54
  经营性应付项目的增加--479,697,287.52--830,705,049.71
  不涉及现金收支的投资和筹资活动金额其他项目---853,585,924.85
  现金的期末余额-9,215,275,522.04-9,391,449,787.11
  减:现金的期初余额-9,391,449,787.11-9,502,388,906.04
  现金及现金等价物的净增加额--176,174,265.07--110,939,118.93
公告日期2025-10-292025-08-272025-04-302025-03-26
审计意见(境内)标准无保留意见
TOP↑